|
| ID |
DDInter1376 |
| Drug Type |
small molecule |
| Molecular Formula |
C23H24N4O3 |
| Molecular Weight |
404.470
|
| Description |
Ozanimod is a sphingosine 1-phosphate receptor modulator being studied to treat Multiple Sclerosis (MS) and inflammatory bowel disease (IBD).
|
| ATC Classification |
L04AA38
|
| IUPAC Name |
5-{3-[(1S)-1-[(2-Hydroxyethyl)Amino]-2,3-Dihydro-1H-Inden-4-Yl]-1,2,4-Oxadiazol-5-Yl}-2-(Propan-2-Yloxy)Benzonitrile |
| InChI |
Inchi=1S/C23H24N4O3/C1-14(2)29-21-9-6-15(12-16(21)13-24)23-26-22(27-30-23)19-5-3-4-18-17(19)7-8-20(18)25-10-11-28/H3-6,9,12,14,20,25,28H,7-8,10-11H2,1-2H3/T20-/M0/S1 |
| InChI Key |
XRVDGNKRPOAQTN-FQEVSTJZSA-N |
| Canonical SMILES |
CC(C)OC1=C(C=C(C=C1)C1=NC(=NO1)C1=C2CC[C@H](NCCO)C2=CC=C1)C#N |
| Useful Links |
DrugBank
ChEMBL
PubChem
|